AFEYAN NOUBAR
Transactions
50
Companies
28
Filings
6
CIK
0001222012
Recent Transactions
- Award
Series 1 Warrants to purchase Common Stock
2026-01-13+1,117,734→ 1,117,734 total - Award
Series 2 Warrants to purchase Common Stock
2026-01-13+1,117,734→ 1,117,734 total - Award
Pre-Funded Warrants to purchase Common Stock
2026-01-13$6.71/sh+2,235,468→ 2,235,468 total - Exercise/Conversion
- Sale
- Exercise/Conversion
- Award
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
Companies
28ACCELERON PHARMA INC
10% Owner
- $AGEN
AGENUS INC
Director
- $AGIO
AGIOS PHARMACEUTICALS, INC.
10% Owner
Axcella Health Inc.
10% Owner
BG Medicine, Inc.
Director, 10% Owner
- $CARM
Carisma Therapeutics Inc.
Director
- $RNAC
Cartesian Therapeutics, Inc.
10% Owner
Codiak BioSciences, Inc.
10% Owner
CONCERT PHARMACEUTICALS, INC.
10% Owner
- $DNLI
Denali Therapeutics Inc.
10% Owner
DNIB UNWIND, INC.
Director, 10% Owner
- $EDIT
Editas Medicine, Inc.
10% Owner
Evelo Biosciences, Inc.
Director, 10% Owner
- $FHTX
Foghorn Therapeutics Inc.
Director, 10% Owner
HELICOS BIOSCIENCES CORP
Director, 10% Owner
Kaleido Biosciences, Inc.
Director, 10% Owner
- $MRNA
Moderna, Inc.
Director
Omega Therapeutics, Inc.
Director, 10% Owner
- $QTRX
Quanterix Corp
10% Owner
Receptos, Inc.
10% Owner
Rubius Therapeutics, Inc.
Director, 10% Owner
- $SANA
Sana Biotechnology, Inc.
10% Owner
- $MCRB
Seres Therapeutics, Inc.
Director, 10% Owner
Sigilon Therapeutics, Inc.
10% Owner
Syros Pharmaceuticals, Inc.
10% Owner
T2 Biosystems, Inc.
10% Owner
TETRAPHASE PHARMACEUTICALS INC
10% Owner
- $TMDX
TransMedics Group, Inc.
10% Owner
Recent Filings
6Address
55 CAMBRIDGE PARKWAY, SUITE 800E
CAMBRIDGE, MA, 02142